187 related articles for article (PubMed ID: 21392577)
21. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease.
Sun Y; Liu Z; Cao X; Lu Y; Mi Z; He C; Liu J; Zheng Z; Li MJ; Li T; Xu D; Wu M; Cao Y; Li Y; Yang B; Mei C; Zhang L; Chen Y
Sci Adv; 2019 Jun; 5(6):eaaw3593. PubMed ID: 31183407
[TBL] [Abstract][Full Text] [Related]
22. The genetics and physiology of polycystic kidney disease.
Calvet JP; Grantham JJ
Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
[TBL] [Abstract][Full Text] [Related]
23. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway.
Xu D; Lv J; He L; Fu L; Hu R; Cao Y; Mei C
FASEB J; 2018 Aug; 32(8):4394-4407. PubMed ID: 29529391
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CFTR Expression and Arginine Vasopressin Activity Are Dependent on Polycystin-1 in Kidney-Derived Cells.
de Lemos Barbosa CM; Souza-Menezes J; Amaral AG; Onuchic LF; Cebotaru L; Guggino WB; Morales MM
Cell Physiol Biochem; 2016; 38(1):28-39. PubMed ID: 26741910
[TBL] [Abstract][Full Text] [Related]
25. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
26. Polycystin-1 expression in fetal, adult and autosomal dominant polycystic kidney.
Chae SW; Cho EY; Park MS; Lee KB; Kim H; Kim U
J Korean Med Sci; 2006 Jun; 21(3):425-9. PubMed ID: 16778383
[TBL] [Abstract][Full Text] [Related]
27. Molecular dysregulation of ciliary polycystin-2 channels caused by variants in the TOP domain.
Vien TN; Wang J; Ng LCT; Cao E; DeCaen PG
Proc Natl Acad Sci U S A; 2020 May; 117(19):10329-10338. PubMed ID: 32332171
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
29. The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid Nanodiscs.
Shen PS; Yang X; DeCaen PG; Liu X; Bulkley D; Clapham DE; Cao E
Cell; 2016 Oct; 167(3):763-773.e11. PubMed ID: 27768895
[TBL] [Abstract][Full Text] [Related]
30. Is it Time to Fold the Cysts Away?
Krappitz M; Gallagher AR; Fedeles S
Trends Mol Med; 2016 Dec; 22(12):997-999. PubMed ID: 27793600
[TBL] [Abstract][Full Text] [Related]
31. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
32. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.
Mekahli D; Decuypere JP; Sammels E; Welkenhuyzen K; Schoeber J; Audrezet MP; Corvelyn A; Dechênes G; Ong AC; Wilmer MJ; van den Heuvel L; Bultynck G; Parys JB; Missiaen L; Levtchenko E; De Smedt H
Pflugers Arch; 2014 Aug; 466(8):1591-604. PubMed ID: 24193408
[TBL] [Abstract][Full Text] [Related]
33. Structure of the human PKD1-PKD2 complex.
Su Q; Hu F; Ge X; Lei J; Yu S; Wang T; Zhou Q; Mei C; Shi Y
Science; 2018 Sep; 361(6406):. PubMed ID: 30093605
[TBL] [Abstract][Full Text] [Related]
34. Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl channel activity in Xenopus oocytes.
Chernova MN; Vandorpe DH; Clark JS; Alper SL
Kidney Int; 2005 Aug; 68(2):632-41. PubMed ID: 16014040
[TBL] [Abstract][Full Text] [Related]
35. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.
Wilson PD; Geng L; Li X; Burrow CR
Lab Invest; 1999 Oct; 79(10):1311-23. PubMed ID: 10532593
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics and autosomal dominant polycystic kidney disease.
Li X
Biochim Biophys Acta; 2011 Oct; 1812(10):1213-8. PubMed ID: 20970496
[TBL] [Abstract][Full Text] [Related]
37. Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.
Aguiari G; Bizzarri F; Bonon A; Mangolini A; Magri E; Pedriali M; Querzoli P; Somlo S; Harris PC; Catizone L; Del Senno L
J Mol Med (Berl); 2012 Nov; 90(11):1267-82. PubMed ID: 22570239
[TBL] [Abstract][Full Text] [Related]
38. Multidrug therapy for polycystic kidney disease: a review and perspective.
Aguiari G; Catizone L; Del Senno L
Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
[TBL] [Abstract][Full Text] [Related]
39. Identification of Biomarkers for PKD1 Using Urinary Exosomes.
Hogan MC; Bakeberg JL; Gainullin VG; Irazabal MV; Harmon AJ; Lieske JC; Charlesworth MC; Johnson KL; Madden BJ; Zenka RM; McCormick DJ; Sundsbak JL; Heyer CM; Torres VE; Harris PC; Ward CJ
J Am Soc Nephrol; 2015 Jul; 26(7):1661-70. PubMed ID: 25475747
[TBL] [Abstract][Full Text] [Related]
40. Role of the polycystins as mechanosensors of extracellular stiffness.
Nigro EA; Boletta A
Am J Physiol Renal Physiol; 2021 May; 320(5):F693-F705. PubMed ID: 33615892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
